Fusion Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Fusion Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 42% to $2,068,000. Profit margin reached -4589%. Total operating expenses were $99,955,000.
Profit Margin
| 2017 | 0 | -6.26M | |
|---|---|---|---|
| 2018 | 0 | -11.65M | |
| 2019 | 0 | -16.18M | |
| 2020 | 0 | -78.33M | |
| 2021 | 1.44M | -81.04M | -5628.26% |
| 2022 | 1.46M | -87.61M | -5996.71% |
| 2023 | 2.06M | -94.89M | -4588.83% |
FUSN Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 2.06M | 1.46M | 1.44M | 0 | 0 | 0 | 0 |
Cost of revenue | 1.34M | 58.89M | 56.35M | 482K | 290K | 0 | 0 |
Gross profit | 723K | -57.43M | -54.91M | -482K | -290K | 0 | 0 |
Operating exp. | |||||||
Research and development | 68.75M | 58.89M | 56.35M | 17.19M | 10.63M | 6.88M | 5.36M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 99.95M | 89.49M | 83.45M | 37.93M | 18.04M | 9.76M | 6.98M |
Operating income | -99.23M | -88.03M | -82.01M | -37.93M | -18.22M | -10.09M | -6.98M |
Other income (expenses), net | 5.12M | -1.41M | 850K | -37.78M | 2.28M | -1.70M | 722K |
Income before tax | -94.11M | -89.44M | -81.16M | -75.72M | -15.93M | -11.47M | -6.26M |
Income tax expense | 787K | -1.83M | -118K | 2.61M | 251K | 181K | 0 |
Net income | -94.89M | -87.61M | -81.04M | -78.33M | -16.18M | -11.65M | -6.26M |
Earnings per share | |||||||
Basic EPS | -1.45 | -2 | -1.9 | -3.56 | -0.1 | -0.62 | -0.34 |
Diluted EPS | -1.45 | -2 | -1.9 | -3.56 | -0.1 | -0.62 | -0.34 |
| Data source | Data source | Data source | Data source |